Loading chat...
NV AB411
Bill
Status
Vetoed
6/5/2025
Primary Sponsor
Sandra Jauregui
Click for details
AI Summary
-
Allows prescriptions for mifepristone, misoprostol, or their generic alternatives to display the health care practice name instead of the individual prescribing practitioner's name on the label
-
Requires the prescribing practitioner to specifically request this alternative labeling option for it to apply
-
Amends NRS 639.2801, which governs mandatory prescription label requirements in Nevada
-
Applies only to medication abortion drugs; all other prescriptions must continue listing the individual prescriber's name as currently required
Legislative Description
Revises provisions relating to prescription drugs. (BDR 54-1100)
Last Action
Vetoed by the Governor.
6/5/2025
Committee Referrals
Commerce and Labor4/23/2025
Health and Human Services3/12/2025
Full Bill Text
No bill text available